Extending overnight fasting duration by 3 hours in alignment with sleep improved cardiometabolic health in middle-aged/older adults by strengthening coordination between circadian- and sleep-regulated autonomic and metabolic activity.
This was a coprimary outcome of the randomized parallel-arm controlled trial.
39 overweight/obese participants aged 36-75 years were randomized to either intervention or control.
The intervention group achieved 13-16 hours of fasting; the control group maintained habitual fasting of 11-13 hours.
Intervention duration was 7.5 weeks.
Both groups dimmed lights 3 hours before bedtime, controlling for light exposure as a potential confounder.
Results
Extended overnight fasting did not significantly improve the Matsuda Index of insulin sensitivity compared to control.
The Matsuda Index was a coprimary outcome.
Failure to reach significance on this measure means only one of the two coprimary outcomes was met.
The intervention window was 7.5 weeks, which may have been insufficient for changes in whole-body insulin sensitivity.
Results
Extended overnight fasting improved nighttime autonomic function, including lower nighttime heart rate and higher heart rate variability.
These were secondary outcome measures.
Lower nighttime heart rate was observed in the intervention group compared to control.
Higher heart rate variability in the intervention group indicates improved autonomic balance.
Improvements suggest strengthened coordination between circadian- and sleep-regulated autonomic activity.
Results
Extended overnight fasting reduced nighttime cortisol levels compared to control.
Nighttime cortisol was a secondary outcome measure.
Lower cortisol during the overnight period is consistent with improved autonomic and metabolic regulation.
Cortisol is involved in cardiometabolic regulation, and its reduction overnight may contribute to the observed blood pressure dipping improvements.
Results
Extended overnight fasting improved morning oral glucose tolerance, including lower glucose levels and a higher 30-minute insulinogenic index during the Oral Glucose Tolerance Test (OGTT).
These were secondary outcome measures assessed via OGTT.
Lower glucose levels during the OGTT indicate improved glucose regulation.
A higher 30-minute insulinogenic index indicates improved acute insulin response.
These improvements occurred despite no significant change in the Matsuda Index of overall insulin sensitivity.
Methods
The sleep-aligned extended overnight fasting approach required participants to consume their last meal at least 3 hours before sleep, extending their habitual overnight fast by approximately 3 hours.
The intervention was individualized based on each participant's habitual sleep time.
Intervention group achieved a fasting window of 13-16 hours.
Control group maintained habitual fasting of 11-13 hours.
This approach differs from existing time-restricted eating protocols by anchoring the fasting window to the individual's sleep schedule rather than using fixed clock-time windows.
The authors describe this as a 'novel, accessible lifestyle intervention.'
Background
Existing time-restricted eating approaches may have limited adherence and sustainability due to fixed fasting windows with prolonged fasting duration before sleep, or involve self-selected fasting windows without specifying duration relative to sleep.
The authors identify this as a key limitation of prior time-restricted eating research.
Sleep is described as 'a critical period for cardiometabolic regulation.'
The sleep-aligned individualized approach was designed to address these adherence and sustainability concerns.
The study population was middle-aged to older adults (36-75 years) who were overweight or obese.
What This Means
This research suggests that simply finishing your last meal of the day at least 3 hours before you go to sleep — and extending the time you spend fasting overnight to roughly 13-16 hours — can meaningfully improve several markers of heart and metabolic health in middle-aged and older adults who are overweight or obese. In a 7.5-week randomized controlled trial, people who followed this sleep-aligned fasting approach showed better nighttime dipping of diastolic blood pressure (a healthy pattern where blood pressure falls during sleep), lower nighttime heart rate, better heart rate variability (a sign of a well-functioning autonomic nervous system), lower overnight cortisol levels, and improved blood sugar responses the next morning compared to people who kept their usual eating habits.
Unlike many popular time-restricted eating plans that set rigid eating windows by the clock (such as eating only between noon and 8 p.m.), this approach was personalized to each person's own sleep schedule. This makes it potentially easier to follow in real life, since the fasting window is anchored to when you naturally sleep rather than to a fixed time. Importantly, the intervention did not significantly improve a standard measure of overall insulin sensitivity (the Matsuda Index), suggesting that some metabolic benefits — particularly around acute blood sugar responses and nighttime cardiovascular regulation — may emerge before broader changes in insulin sensitivity.
This research suggests that the timing of meals relative to sleep, not just the total duration of fasting, matters for cardiometabolic health. By aligning fasting with the body's natural overnight regulatory rhythms — which govern both the heart and metabolism — this approach appears to enhance the body's ability to lower blood pressure and regulate blood sugar. The findings point to a practical and accessible dietary strategy that could help reduce cardiovascular and metabolic risk in older adults, though longer-term studies with larger groups would be needed to confirm and extend these results.